These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 29018160)

  • 1. Dopamine dysregulation syndrome in Parkinson's disease: a systematic review of published cases.
    Warren N; O'Gorman C; Lehn A; Siskind D
    J Neurol Neurosurg Psychiatry; 2017 Dec; 88(12):1060-1064. PubMed ID: 29018160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.
    O'Sullivan SS; Evans AH; Lees AJ
    CNS Drugs; 2009; 23(2):157-70. PubMed ID: 19173374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of impaired motor and cognitive volition in Parkinson's disease: Correlates of dopamine dysregulation syndrome, impulse control disorder, and dyskinesias.
    Hinkle JT; Perepezko K; Rosenthal LS; Mills KA; Pantelyat A; Mari Z; Tochen L; Bang JY; Gudavalli M; Yoritomo N; Butala A; Bakker CC; Johnson V; Moukheiber E; Dawson TM; Pontone GM
    Parkinsonism Relat Disord; 2018 Feb; 47():50-56. PubMed ID: 29198499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural adverse effects of dopaminergic treatments in Parkinson's disease: incidence, neurobiological basis, management and prevention.
    Antonini A; Cilia R
    Drug Saf; 2009; 32(6):475-88. PubMed ID: 19459715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of STN and GPi deep brain stimulation on impulse control disorders and dopamine dysregulation syndrome.
    Moum SJ; Price CC; Limotai N; Oyama G; Ward H; Jacobson C; Foote KD; Okun MS
    PLoS One; 2012; 7(1):e29768. PubMed ID: 22295068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine dysregulation syndrome in Parkinson's disease: from clinical and neuropsychological characterisation to management and long-term outcome.
    Cilia R; Siri C; Canesi M; Zecchinelli AL; De Gaspari D; Natuzzi F; Tesei S; Meucci N; Mariani CB; Sacilotto G; Zini M; Ruffmann C; Pezzoli G
    J Neurol Neurosurg Psychiatry; 2014 Mar; 85(3):311-8. PubMed ID: 23591553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impulse Control and Related Disorders in Parkinson's Disease.
    Weintraub D; Claassen DO
    Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson's disease.
    Sriram A; Ward HE; Hassan A; Iyer S; Foote KD; Rodriguez RL; McFarland NR; Okun MS
    J Neurol; 2013 Feb; 260(2):521-7. PubMed ID: 23007193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addiction-like manifestations and Parkinson's disease: a large single center 9-year experience.
    Limotai N; Oyama G; Go C; Bernal O; Ong T; Moum SJ; Bhidayasiri R; Foote KD; Bowers D; Ward H; Okun MS
    Int J Neurosci; 2012 Mar; 122(3):145-53. PubMed ID: 22023411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Syndrome dopamine dysregulation and deep brain stimulation of the subthalamic nucleus in Parkinson's disease].
    Omarova SM; Fedorova NV; Tomskiy AA; Gamaleya AA; Bril' EV; Gubareva NN; Poddubskaya AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12):27-32. PubMed ID: 29376980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease.
    Lim SY; O'Sullivan SS; Kotschet K; Gallagher DA; Lacey C; Lawrence AD; Lees AJ; O'Sullivan DJ; Peppard RF; Rodrigues JP; Schrag A; Silberstein P; Tisch S; Evans AH
    J Clin Neurosci; 2009 Sep; 16(9):1148-52. PubMed ID: 19553125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.
    Lhommée E; Klinger H; Thobois S; Schmitt E; Ardouin C; Bichon A; Kistner A; Fraix V; Xie J; Aya Kombo M; Chabardès S; Seigneuret E; Benabid AL; Mertens P; Polo G; Carnicella S; Quesada JL; Bosson JL; Broussolle E; Pollak P; Krack P
    Brain; 2012 May; 135(Pt 5):1463-77. PubMed ID: 22508959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series.
    Gallagher DA; O'Sullivan SS; Evans AH; Lees AJ; Schrag A
    Mov Disord; 2007 Sep; 22(12):1757-63. PubMed ID: 17580327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease.
    Eusebio A; Witjas T; Cohen J; Fluchère F; Jouve E; Régis J; Azulay JP
    J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):868-74. PubMed ID: 23447648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine dysregulation syndrome in non-Parkinson's disease patients: a systematic review.
    Cartoon J; Ramalingam J
    Australas Psychiatry; 2019 Oct; 27(5):456-461. PubMed ID: 31032624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Not Available].
    Corvol JC
    Bull Acad Natl Med; 2014 Oct; 198(7):1297-307; discussion 1307-8. PubMed ID: 27120903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical spectrum of impulse control disorders in Parkinson's disease.
    Weintraub D; David AS; Evans AH; Grant JE; Stacy M
    Mov Disord; 2015 Feb; 30(2):121-7. PubMed ID: 25370355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addiction in Parkinson's disease: impact of subthalamic nucleus deep brain stimulation.
    Witjas T; Baunez C; Henry JM; Delfini M; Regis J; Cherif AA; Peragut JC; Azulay JP
    Mov Disord; 2005 Aug; 20(8):1052-5. PubMed ID: 15858803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome].
    Bayard S; Cochen De Cock V; Dauvillers Y
    Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):227-35. PubMed ID: 21690031
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.